Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese Participants

Trial Identifier:	D9182C00002
Sponsor:	AstraZeneca
NCTID::	NCT05070312
Start Date:	August 2021
Primary Completion Date:	February 2022
Study Completion Date:	February 2022
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Suzhou, CN, 215006

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.